Teva Pharmaceutical Industries | TEVA - Operating Expenses

Stock Price
9,290.00
Daily Change
-84.00 -0.90%
Monthly
-11.78%
Yearly
56.48%
Q1 Forecast
9,016.87

Teva Pharmaceutical Industries reported $4.22B in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Aspen Pharmacare ZAR 18.69B 1.51B Jun/2025
Cipla INR 60.98B 1.06B Dec/2025
Dr.Reddys Laboratories INR 73.6B 1.79B Dec/2025
Guangzhou Baiy CNY 18.43B 60.19M Sep/2025
Jiangsu Hengrui CNY 5.94B 254.97M Sep/2025
Kalbe Farma IDR 8.06T 883.47B Sep/2025
Richter Gedeon HUF 151.11B 1.91B Sep/2025
Sh Fosun Pharma CNY 9.12B 194.06M Sep/2025
Sun Pharmaceuticals INR 111.11B 6.97B Sep/2025
Teva Pharmaceutical Industries USD 4.22B 812M Dec/2025